Back to search
S 2783 - 102

Medical Device Amendments of 1992

Became Public Law No: 102-300.

Bill Text Stats

Bill text analysis is not available for this record yet.

Affected Sectors

How to read this

Sectors are deterministic matches from official Congress.gov data and cached bill text. They are source-derived signals, not conclusions about intent or economic effect.

Evidence matches count official fields, normalized subjects, cached text snippets, or extracted entities that matched the sector rules.

Impact is a bill-level rollup used for sorting and filtering. It is not an economic impact estimate.

Confidence is the strongest individual match score behind that sector.

Evidence snippets show why a sector matched and can repeat when Congress.gov repeats the same phrase across official fields.

Healthcare
2 evidence matches
Impact 99% Confidence 90%

Health

Medical Device Amendments of 1992 Became Public Law No: 102-300. Health

CBO Cost Estimates

Official Congressional Budget Office cost estimate links associated with this bill through Congress.gov records.

How to read this

CBO estimates are official source documents with their own assumptions, scope, and publication dates. They can score a bill, a version of a bill, or a broader legislative package.

LawLinter stores the source link from Congress.gov and does not replace the CBO document. Use these cards as pointers for source review, not as independent fiscal advice.

CBO context shows source-attributed Congressional Budget Office cost estimates linked from official Congress.gov bill records. It is research context only; read the official CBO source document for assumptions, scope, and dates.

No CBO cost estimate is currently linked for this bill.

Campaign Finance Context

Related FEC/OpenFEC campaign-finance records for lawmakers and candidates tied to this bill through source-attributed legislative relationships. These are not donations to the bill itself.

How to read this

Amounts shown here are campaign-finance totals for sponsor or cosponsor-linked candidates and their committees in the displayed FEC cycle.

They are not donations to this bill, spending on this bill, or proof that money influenced or caused sponsorship, cosponsorship, votes, or legislative outcomes.

If multiple linked lawmakers have FEC records, this section can show multiple candidate cards and separate sponsor/cosponsor rollups.

Campaign-finance context uses source-attributed FEC/OpenFEC records that are related or relevant to the displayed bill, lawmaker, candidate, committee, or legislative relationship through deterministic links. It is research context only, not proof of influence, causation, endorsement, or that money caused a sponsorship, vote, or legislative outcome.

No FEC/OpenFEC campaign-finance context is currently linked for this bill.

Lobbying Context

Related LDA.gov filings where public lobbying activity descriptions reference this bill. These records are source-attributed research context, not evidence of influence or causation.

How to read this

LDA filings are public lobbying disclosure records. LawLinter links them here only when the filing activity text contains an exact-looking reference to this bill.

A filing can mention many issues, clients, agencies, or bills. A match should be treated as a pointer for review, not as a conclusion about why legislation changed or how any lawmaker acted.

Lobbying context uses source-attributed LDA.gov records that appear related to this bill through bill references in public lobbying activity descriptions. It is research context only, not proof of influence, causation, endorsement, lobbying effectiveness, or legislative intent.

No LDA.gov lobbying disclosure context is currently linked for this bill.

Summary

00 Introduced in Senate Apr 18, 2002

Medical Device Amendments of 1992 - Amends the Safe Medical Devices Act of 1990 to extend the deadline for the Food and Drug Administration (FDA) to issue final regulations under the Federal Food, Drug, and Cosmetic Act (FFDC Act) with respect to medical device tracking until November 28 (currently, May 28), 1992. Specifies that if the Secretary does not promulgate such final regulations by that date, the proposed regulations shall become the final regulations and the FDA shall promptly publish in the Federal Register notice of the new status. Makes: (1) failure to comply with a requirement imposed by provisions of the FFDC Act concerning postmarket surveillance a prohibited act subject to criminal and civil penalties; and (2) any device product misbranded if there was a failure or refusal to comply with postmarket surveillance requirements. Directs each manufacturer required to conduct a surveillance of a device to submit, for the approval of the Secretary of Health and Human Services, a protocol for the required surveillance. Authorizes the FDA to order a manufacturer, importer, or distributor to repair or replace a device, or refund the purchase price to the customer, where the device was improperly designed or manufacturered. Revises reporting requirements, including adding requirements for: (1) a device manufacturer or importer to report to the Secretary whenever the manufacturer or importer receives or otherwise becomes aware of information that reasonably suggests that one of its marketed devices may have caused or contributed to a death or serious injury (defined as an injury that is life threatening, results in permanent impairment of a body function or permanent damage to a body structure, or necessitates medical or surgical intervention to preclude such permanent impairment or damage), or has malfunctioned and that such device or a similar device marketed by the manufacturer or importer would be likely to cause or contribute to a death or serious injury if the malfunction were to recur; and (2) reporting of other significant adverse device experiences as determined by the Secretary to be necessary to be reported.

Sponsors

Timeline

Jun 16, 1992

Signed by President.

Jun 16, 1992

Signed by President.

Jun 16, 1992

Became Public Law No: 102-300.

Jun 16, 1992

Became Public Law No: 102-300.

Jun 4, 1992

Presented to President.

Jun 4, 1992

Presented to President.

Jun 2, 1992

Message on House action received in Senate.

May 28, 1992

Considered by unanimous consent.

May 28, 1992

Mr. Waxman asked unanimous consent to take from the Speaker's table and consider.

May 28, 1992

Passed/agreed to in House: On passage Passed without objection.

May 28, 1992

On passage Passed without objection.

May 28, 1992

Motion to reconsider laid on the table Agreed to without objection.

May 26, 1992

Received in the House.

May 26, 1992

Held at the desk.

May 21, 1992

Introduced in Senate

May 21, 1992

Passed/agreed to in Senate: Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Voice Vote.

May 21, 1992

Introduced in the Senate, read twice, considered, read the third time, and passed without amendment by Voice Vote.

House Votes

No House roll call votes have been linked to this bill yet.

Amendments

No amendment records are currently available for this bill.
Compiled bill record. Bill pages combine Congress.gov source payloads, normalized relationships, cached text analysis, vote links, and deterministic sector/signal extraction. This is not an official government record or legal advice; use the official source link when accuracy matters.